Ratings by BMO Capital (Gary Nachman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/11/2026 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2024 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2024 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/5/2024 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2023 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 7/28/2023 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/17/2023 | Evelo Biosciences Inc | EVLO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2023 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2023 | Amneal Pharmaceuticals | AMRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/1/2023 | Phathom Pharmaceuticals | PHAT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2023 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/22/2023 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2023 | Sage Therapeutics | SAGE | Maintain | Underperform (N/A) |
|
Details | ||
| 2/17/2023 | Viatris | VTRS | Downgrade | Market Perform (Outperform) |
11.85 (16.17) |
36.46% | Details | |
| 2/6/2023 | Evelo Biosciences Inc | EVLO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/6/2023 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 1/6/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/4/2023 | Phathom Pharmaceuticals | PHAT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2022 | Horizon Therapeutics | HZNP | Downgrade | Market Perform (Outperform) |
97.29 (116.30) |
19.54% | Details | |
| 11/14/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2022 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2022 | 9 Meter Biopharma | NMTR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2022 | Sage Therapeutics | SAGE | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/7/2022 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/7/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/4/2022 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2022 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2022 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 8/15/2022 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2022 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/3/2022 | Sage Therapeutics | SAGE | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/3/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2022 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2022 | PolyPid Ltd. | PYPD | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2022 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/11/2022 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2022 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2022 | Amneal Pharmaceuticals | AMRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/29/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/25/2022 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 4/7/2022 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/10/2022 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2022 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/3/2022 | Endo International plc | ENDP | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/3/2022 | Phathom Pharmaceuticals | PHAT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2022 | Viatris | VTRS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/25/2022 | Schrodinger | SDGR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2022 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2022 | Sage Therapeutics | SAGE | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/23/2022 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 2/14/2022 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/3/2022 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 1/13/2022 | Rigel Pharmaceuticals | RIGL | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2022 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/17/2021 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2021 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/10/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/5/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/1/2021 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/12/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/12/2021 | Flexion Therapeutics | FLXN | Downgrade | Market Perform (Outperform) |
5.78 (24.88) |
330.45% | Details | |
| 9/20/2021 | AbCellera Biologics | ABCL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2021 | Sage Therapeutics | SAGE | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/5/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/8/2021 | 9 Meter Biopharma | NMTR | New Coverage | Outperform (N/A) |
1.07 (0.07) |
-93.46% | Details | |
| 5/3/2021 | Abbvie | ABBV | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2021 | Flexion Therapeutics | FLXN | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/4/2021 | Optinose | OPTN | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/1/2021 | Amneal Pharmaceuticals | AMRX | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/26/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/26/2021 | Endo International plc | ENDP | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/25/2021 | Bausch Health Companies | BHC | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/25/2021 | Sage Therapeutics | SAGE | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 2/24/2021 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2021 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2021 | Phathom Pharmaceuticals | PHAT | New Coverage | Outperform (N/A) |
44.58 (9.25) |
-79.25% | Details | |
| 1/22/2021 | Sage Therapeutics | SAGE | Downgrade | Market Perform (Outperform) |
92.44 (8.68) |
-90.61% | Details | |
| 1/13/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/17/2020 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 11/30/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/18/2020 | Abbvie | ABBV | New Coverage | Outperform (N/A) |
98.36 (258.92) |
163.24% | Details | |
| 11/10/2020 | Neos Therapeutics | NEOS | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2020 | Endo International plc | ENDP | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/6/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2020 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/2/2020 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2020 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 10/13/2020 | Flexion Therapeutics | FLXN | Maintain | Outperform (N/A) |
|
Details | ||
| 9/11/2020 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/4/2020 | Mallinckrodt plc | MNK | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/21/2020 | PolyPid Ltd. | PYPD | New Coverage | Outperform (N/A) |
15.61 (4.73) |
-69.7% | Details | |
| 7/21/2020 | Flextronics | FLEX | New Coverage | Outperform (N/A) |
10.98 (120.24) |
995.08% | Details | |
| 5/7/2020 | Lannett Co | LCI | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/7/2020 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 5/6/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 4/8/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 3/6/2020 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2020 | Optinose | OPTN | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/28/2020 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2020 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2020 | Mallinckrodt plc | MNK | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/26/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2020 | Mallinckrodt plc | MNK | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/13/2020 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/22/2020 | Horizon Therapeutics | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/27/2019 | Flexion Therapeutics | FLXN | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2019 | Horizon Pharma | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/16/2019 | Horizon Pharma | HZNP | Maintain | Outperform (N/A) |
|
Details | ||
| 12/6/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/18/2019 | Trevi Therapeutics | TRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2019 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/11/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/8/2019 | Amphastar Pharmaceuticals | AMPH | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/5/2019 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/5/2019 | Sienna Biopharmaceuticals | SNNA | Maintain | Outperform (N/A) |
|
Details | ||
| 9/5/2019 | Mallinckrodt plc | MNK | Downgrade | Market Perform (Outperform) |
2.55 (0.34) |
-86.67% | Details | |
| 8/28/2019 | Lannett Co | LCI | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/14/2019 | Horizon Pharma | HZNP | Upgrade | Outperform (Market Perform) |
26.22 (116.30) |
343.55% | Details | |
| 8/13/2019 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2019 | Neos Therapeutics | NEOS | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/12/2019 | Endo International plc | ENDP | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/9/2019 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/9/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/8/2019 | Amphastar Pharmaceuticals | AMPH | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/7/2019 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Mallinckrodt plc | MNK | Maintain | Outperform (N/A) |
|
Details | ||
| 8/7/2019 | Flexion Therapeutics | FLXN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/3/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2019 | Trevi Therapeutics | TRVI | New Coverage | Outperform (N/A) |
9.11 (19.07) |
109.33% | Details | |
| 5/22/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/21/2019 | Mallinckrodt plc | MNK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2019 | Sienna Biopharmaceuticals | SNNA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2019 | Neos Therapeutics | NEOS | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/8/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/8/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2019 | Mallinckrodt plc | MNK | Maintain | Outperform (N/A) |
|
Details | ||
| 5/7/2019 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/3/2019 | Teva Pharma | TEVA | Maintain | Market Perform (N/A) |
|
Details | ||
| 5/3/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/4/2019 | Horizon Pharma | HZNP | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/28/2019 | Teva Pharma | TEVA | New Coverage | Market Perform (N/A) |
15.93 (36.58) |
129.63% | Details | |
| 3/22/2019 | scPharmaceuticals | SCPH | Maintain | Outperform (N/A) |
|
Details | ||
| 3/22/2019 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/15/2019 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 3/13/2019 | Amphastar Pharmaceuticals | AMPH | Maintain | Market Perform (N/A) |
|
Details | ||
| 3/1/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/27/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2019 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/21/2019 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 2/7/2019 | Lannett Co | LCI | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/31/2019 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 1/17/2019 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/16/2019 | Aptinyx | APTX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2019 | Sage Therapeutics | SAGE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/4/2018 | Sienna Biopharmaceuticals | SNNA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/26/2018 | Aquestive Therapeutics | AQST | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2018 | Amphastar Pharmaceuticals | AMPH | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/8/2018 | Lannett Co | LCI | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/8/2018 | Horizon Pharma | HZNP | Maintain | Market Perform (N/A) |
|
Details | ||
| 11/7/2018 | Jazz Pharmaceuticals | JAZZ | Maintain | Outperform (N/A) |
|
Details | ||
| 11/6/2018 | Mylan | MYL | Maintain | Outperform (N/A) |
|
Details | ||
| 11/2/2018 | Pacira Pharmaceuticals | PCRX | Maintain | Market Perform (N/A) |
|
Details | ||
| 9/12/2018 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/20/2018 | Aquestive Therapeutics | AQST | New Coverage | Outperform (N/A) |
16.10 (4.32) |
-73.17% | Details | |
| 8/15/2018 | Optinose | OPTN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2018 | Endo International plc | ENDP | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/13/2018 | Bausch Health Companies | BHC | Maintain | Market Perform (N/A) |
|
Details | ||
| 8/12/2018 | Neos Therapeutics | NEOS | Maintain | Market Perform (N/A) |
|
Details |
